Dr Reddys Laboratories Share Price Today - Live Blog for October 27, 2025

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,282.80. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6600, while the industry PE is 34.9088.

With a remarkable 0.27% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,285.45. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.6600, while the industry's PE ratio is 34.9088.

Dr Reddys Laboratories Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,283.55. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.11%, reaching the current market price of ₹1,284.15. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.05%, signalling a challenging period. Currently trading at ₹1,282.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.35% in its share price, and it currently trades at ₹1,284.90 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.01% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,289.10 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's stock has surged by 0.16%, and it is currently trading at ₹1,289.00. Additionally, the stock maintains a PE ratio of 18.6600, while the industry PE is 34.9088.

Following a noteworthy 0.16% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,289.00. When it comes to valuation, this stock has a PE ratio of 18.6600, with the industry PE ratio at 34.9088.

Dr Reddys Laboratories Ltd's share price has fallen by -0.19%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,288.20, and market participants are assessing the implications. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

After a -0.19% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,288.20. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,290.60, and market participants are assessing the implications. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,290.10. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd witnessed a substantial 0.25% increase in its share price and is currently trading at ₹1,290.50. This remarkable performance has caught the eye of investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.15% increase. Presently, it is actively trading at ₹1,288.00.

After a -0.09% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,285.30. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.15% increase and currently trading at ₹1,286.50 per share. This upward trajectory is turning heads in the market.

There was no shift in the share price of Dr Reddys Laboratories Ltd, which stands at ₹1,284.60. This static period invites investors to consider the stock's fundamental strengths and weaknesses.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.07%, with its current market value per share resting at ₹1,285.15. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.42%, and as of now, it's trading at ₹1,285.10 per share. This upward trajectory is attracting keen interest from investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.18% drop, and it's now trading at ₹1,279.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -0.29% dip in its share price and is currently trading at ₹1,282.10. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd observed a -0.29% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,282.10. The stock has a PE ratio of 18.6600, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd plunged by -0.29%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,282.10, but investors are assessing whether this is a temporary dip or a long-term trend.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.26% gain, with the share price now at ₹1,287.10. Notably, the stock's PE ratio stands at 18.6600, and its Return on Equity (ROE) is 16.0277%.

The share price of Dr Reddys Laboratories Ltd experienced a -0.19% slump and is currently trading at ₹1,284.55. While the stock maintains a PE ratio of 18.6600, the industry PE is 34.9088, raising questions about valuation.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.36%, reaching the current market price of ₹1,285.60. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

After a notable 0.43% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,282.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

The stock of Dr Reddys Laboratories Ltd suffered a -0.35% drop, and it's now trading at ₹1,275.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.